References
Chamot AM, Benhamou CL, Kahn MF, Beraneck L, Kaplan G, Prost A (1987) Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 Cases. Rev Rhum Mal Osteoartic 54(3):187–196
Benhamou CL, Chamot AM, Kahn MF (1988) Synovitis-acne-pustulosis hyperostosis-osteomyelitis syndrome (SAPHO). A new syndrome among the spondyloarthropathies? Clin Exp Rheumatol 6(2):109–112
Hayem G (2007) Valuable lessons from SAPHO syndrome. Joint Bone Spine 74(2):123–126
Moll C, Hernandez MV, Canete JD et al (2008) Ilium osteitis as the main manifestation of the SAPHO syndrome: response to infliximab therapy and review of the literature. Semin Arthritis Rheum 37(5):299–306
Depasquale R, Kumar N, Lalam RK et al (2012) SAPHO: what radiologists should know. Clin Radiol 67(3):195–206
Colina M, Govoni M, Orzincolo C, Trotta F (2009) Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a single center study of a cohort of 71 subjects. Arthritis Rheum 61(6):813–821
Hurtado-Nedelec M, Chollet-Martin S, Nicaise-Roland P et al (2008) Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome. Rheumatology (Oxford) 47(8):1160–1167
Massara A, Cavazzini PL, Trotta F (2006) In SAPHO syndrome anti-TNF-alpha therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations. Rheumatology (Oxford) 45(6):730–733
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Anić, B., Padjen, I., Barešić, M. et al. The lobster sign in SAPHO syndrome: unusually extensive osteitis of the anterior chest wall partially responsive to infliximab. Rheumatol Int 34, 281–282 (2014). https://doi.org/10.1007/s00296-012-2606-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-012-2606-y